Synthesis of analogues of (-)-cytisine for in vivo studies of nicotinic receptors using positron emission tomography

Organic Letters

Volumn 2, Issue 8, 2000, Pages 1121-1124

  Marrière, Eddie ^a   Rouden, Jacques ^a   Tadino, Vincent ^a   Lasne, Marie Claire ^a  

^a UNIVERSITÉ DE CAEN   (France)

Author keywords

[No Author keywords available]

Indexed keywords

ALKALOID; AZOCINE DERIVATIVE; CYTISINE; NICOTINIC RECEPTOR; PALLADIUM; QUINOLIZINE DERIVATIVE;

ARTICLE; CHEMISTRY; COMPUTER ASSISTED EMISSION TOMOGRAPHY; METABOLISM; SYNTHESIS;

ALKALOIDS; AZOCINES; PALLADIUM; QUINOLIZINES; RECEPTORS, NICOTINIC; TOMOGRAPHY, EMISSION-COMPUTED;

EID: 0034689851     PISSN: 15237060     EISSN: None     Source Type: Journal    
DOI: 10.1021/ol005685m     Document Type: Article

References (58)

1. For a review on nAChRs as targets for drug discovery, see: Holladay, M. W.; Dart, M. J.; Lynch, J. K. J. Med. Chem. 1997, 40, 4169.
2. (a) Williams, M.; Sullivan, J. P.; Arneric, S. P. Drug News Perspect. 1994, 7, 205.
3. (b) Perry, E. K.; Morris, C. M.; Court, J. A.; Cheng, A.; Fairbairn, A. F.; McKeith, I. G.; Irving, D.; Brown, A.; Perry, R. H. Neuroscience 1995, 64, 385.
4. Fowler, J. S.; Wolf, A. P. Acc. Chem. Res. 1997, 30, 181.
5. Maziere, M. Pharmacol. Ther. 1995, 66, 83.
6. (a) Muzic, R. F.; Berridge, M. S.; Friedland, R. P.; Zhu, N.; Nelson, A. D. J. Nucl. Med. 1998, 39, 2048.
7. (b) Sihver, W.; Fasth, K. J.; Ögren, M.; Bivehed, H.; Bergström, M.; Nordberg, A.; Watanabe, Y.; Langström, B. J. Neurochem. 1998, 71, 1750.
8. (c) Kassiou, M.; Scheffel, U. A.; Ravert, H. T.; Mathews, W. B.; Musachio, J. L.; London, E. D.; Dannals, R. F. Life Sci. 1998, 63, PL13.
9. (d) Valette, H.; Bottlaender, M.; Dolle, F.; Dolci, L.; Syrota, A.; Crouzel, C. Nucl. Med. Commun. 1997, 18, 164.
10. (e) Patt, J. T.; Spang, J. E.; Westera, G.; Buck, A.; Schubiger, P. A. Nucl. Med. Biol. 1999, 26, 165.
11. (f) Horti, A. G.; Scheffel, U.; Kimes, A. S.; Musachio, J. L.; Ravert, H. T.; Mathews, W. B.; Zhan, Y.; Finley, P. A. London, E. D.; Dannals, R. F. J. Med. Chem. 1998, 41, 4199.
12. (g) Ding, Y. S.; Molina, P. E.; Fowler, J. S.; Logan, J.; Volkow, N. D.; Kuhar, M. J.; Carroll, F. I. Nucl. Med. Biol. 1999, 26, 139.
13. (a) Saji, H.; Watanabe, A.; Magata, Y.; Ohmomo, Y.; Kiyono, Y. Chem. Pharm. Bull. 1997, 45, 284.
14. (b) Musachio, J. L.; Villemagne, V. L.; Scheffel, U.; Stathis, M.; Finley, P.; Horti, A.; London, E. D.; Dannals, R. F. Synapse 1997, 26, 392.
15. (c) Musachio, J. L.; Scheffel, U.; Finley, P. A.; Zhan, Y.; Mochizuki, T.; Wagner, H. N. J.; Dannals, R. F. Life Sci. 1998, 62, PL351.
16. Leonard, N. J. In The alkaloids; Manske, R. H. F., Holmes, H. L., Eds.; Academic Press: New York, 1953; Vol. 3, pp 119-199
17. O'Neill, B. T. PCT Int. Appl. WO98 18,798, 1998; Chem. Abstr. 1998, 119, 4774k.
18. Canu Boido, C.; Sparatore, F. Farmaco 1999, 54, 438.
19. (a) Nitration: Demushkin, V. P.; Kotelevtsev, Y. V. Biorg. Khim. 1982, 8, 621.
20. (b) Bromination and chlorination: Orjales, A.; Ribas. I.; Varela, A. An. Quim. 1972, 68, 1419.
21. Anderson, D. J.; Arneric, S. P. Eur. J. Pharmacol. 1994, 253, 261.
22. (a) Pabreza, L. A.; Dhawan, S.; Kellar, K. J. Mol. Pharmacol. 1991, 39, 9.
23. (b) Glennon, R. A.; Dukat. M. Med. Chem. Res. 1996, 465.
24. (c) Hall, M.; Zerbe, L.; Leonard, S.; Freedman, R. Brain Res. 1993, 600, 127.
25. Sloan, J. W.; Martin, W. R.; Bostwick, M.; Hook, R.; Wala, E. Pharmacol. Biochem. Behav. 1988, 30, 255.
26. (a) Lippiello, P. M.; Caldwell, W. S. US 5242,916, 1993. Chem. Abstr. 1993, 119, 217429g.
27. (b) Romano, C.; Goldstein, A.; Jewel, N. P. Psychopharmacology 1981, 74, 310.
28. Flesher, J. E.; Scheffel, U.; London, E. D.; Frost, J. J. Life Sci. 1994, 54, 1883.
29. (a) Murakoshi, I.; Fujii, Y.; Takedo, S.; Arai, J Japanese Patent 04-295480, 1992; Chem. Abstr. 1993, 118, 45733.
30. (b) Murakoshi, I.; Fujii, Y.; Kawamura, H.; Marayama, H. Japanese Patent 04-295479, 1992; Chem. Abstr. 1993, 118, 45734.
31. Fowler, J. S.; Wolf, A. P. In Positron Emission Tomography and Autoradiography: Principles and Applications for the Brain and Heart; Phelps. M., Maziotta, J., Schelbert, H., Eds.; Raven Press: New York, 1986; p 391 and references therein.
32. (a) Lecoq, H. Bull. Soc. Chim. Fr. 1943, 153.
33. (b) El-Shazly, A.; Sarg, T.; Ateya, A.; Aziz, E. A.; Witte, L.; Wink, M. Pharmazie 1996, 51, 768.
34. Roe, A. Org. React. 1949, 5, 193 and references therein.
35. Knöchel, A.; Zwernemann, O. Appl. Radiat. Isot. 1991, 42, 1077.
36. Minor, J. T.; Hawkins, G. F.; VanderWerf, C. A.; Roe, A. J. Am. Chem. Soc. 1949, 71, 1125.
37. Newman, M. S.; Lilje, K. C. J. Org. Chem. 1979, 44, 1347.
38. Roe, A.; Hawkins, G. F. J. Am. Chem. Soc. 1947, 69, 2443
39. Leznoff, C. C.; Svirskaya, P. I.; Yedidia, V.; Miller, J. M. J. Heterocycl. Chem. 1985, 22, 145.
40. Bergmann, E. D.; Bentov, M. J. Org. Chem. 1954, 19, 1594.
41. Ferm, R. L.; VanderWerf, C. A. J. Am. Chem. Soc. 1950, 72, 4809.
42. Saidova, F. M.; Binchkauskas, V. S.; Khorev, S. G.; Enikeev, E. Y. J. Org. Chem. USSR (Engl. Transl.) 1981, 17, 353.
43. Meng, J.-B.; Shen, M.-Q.; Wang, X.-H.; Kao, C.-H.; Wang, R.-J. J. Heterocycl. Chem. 1991, 28, 1481.
44. (a) Earl, R. A.; Vollhardt, K. P. C. J. Org. Chem. 1984, 49, 4786.
45. (b) Barr, S. A.; Neville, C. F.; Grundon, M. F.; Boyd, D. R.; Malone, J. F.; Evans, T. A. J. Chem. Soc., Perkin Trans. 1 1995, 4, 445.
46. (c) Snyder, L.; Shen, W.; Bornmann, W. G.; Danishefsky, S. J. J. Org. Chem. 1994, 59, 703.
47. Devadas, B.; Rogers, T. E.; Gray, S. H. Synth. Commun. 1995, 25, 3199.
48. Timari, G.; Soos, T.; Hajos, G. Synlett 1997, 1067.
49. Knight, D. W. In Comprehensive Organic Synthesis; Trost B., Fleming, I., Eds.; Pergamon Press: New York, 1993; Vol. 4, pp 481-516.
50. Merkushev, E. B. Synthesis 1988, 923.
51. Affinities and selectivities of the synthesized compounds were measured by Samir Jegham and Olivier Curet, Synthelabo, Bagneux, France, and the data will be published in due time.
52. Stille, J. K. Angew. Chem., Int. Ed. Engl. 1986, 25, 508.
53. Fugita, M.; Oka, H.; Ogura, K. Tetrahedron Lett. 1995, 36, 5247.
54. Farina, V.; Krishnan, B. J. Am. Chem. Soc. 1991, 113, 9585.
55. (a) Allain-Barbier, L.; Lasne, M. C.; Perrio-Huard, C.; Moreau, B.; Barré, L. Acta Chem. Scand. 1998, 52, 480.
56. (b) Forngren, T.; Andersson, Y.; Lamm, B.; Langström, B. Acta Chem. Scand. 1998, 52, 475.
57. f or retention times with those of authentic samples in radio-TLC and/or HPLC.
58. 18F]-KF. Under these conditions, no attempt was made to measure the specific radioactivity.